PLA2R1 and membranous glomerulonephritis: The discovery of target antigens has created a greater heterogeneity in membranous nephropathy that can be defined by detecting autoantibodies using serological methods or by renal expression of PLA2R and THSD7A in renal biopsy specimens [2,26].